Dr. Weiland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2116 Craig Rd
Eau Claire, WI 54701Phone+1 715-858-4500Fax+1 715-858-4502
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1989 - 1993
- Virginia Mason Franciscan HealthInternship, Transitional Year, 1988 - 1989
- Mayo Clinic College of MedicineClass of 1988
Certifications & Licensure
- MI State Medical License 2022 - 2025
- MN State Medical License 1989 - 2025
- ND State Medical License 1994 - 2025
- WI State Medical License 2017 - 2025
- WA State Medical License 1988 - 1989
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- 73 citationsMEG3-4 is a miRNA decoy that regulates IL-1β abundance to initiate and then limit inflammation to prevent sepsis during lung infection.Rongpeng Li, Lizhu Fang, Qinqin Pu, Huimin Bu, Pengcheng Zhu
Science Signaling. 2018-06-26 - 7 citationsNoncritically phase-matched fourth harmonic generation of Nd:glass lasers in partially deuterated KDP crystalsSteven T. Yang, Mark A. Henesian, Timothy L. Weiland, James L. Vickers, Ronald L. Luthi
Optics Letters. 2011-05-15 - 51 citationsAlternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National...Steven R. Alberts, Mark S. Roh, Michelle R. Mahoney, Michael J. O'Connell, David M. Nagorney
Journal of Clinical Oncology. 2010-02-10
Journal Articles
- MEG3-4 Is a miRNA Decoy That Regulates IL-1β Abundance to Initiate and Then Limit Inflammation to Prevent Sepsis During Lung InfectionMin Wu, Timothy Weiland, Science Magazine
Grant Support
- PathologyNational Cancer Institute2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: